Clinical management of angioneurotic oedema patient post-orthognathic surgery.
Angioneurotic oedema is an acute swelling involving the submucosal or subcutaneous tissues; it is most often located in the oral and maxillofacial region, which can result in upper airway obstruction. Its aetiology is frequently associated with immunoglobulin-mediated hypersensitivity reactions that elicit a heightened inflammatory response. The objective of this study was to report the case of a patient who developed an episode of angioneurotic oedema following combined orthognathic surgery. Pharmacological and nonpharmacological interventions used in the treatment of this important clinical condition are described and discussed.
Puricelli
E
E
Oral and Maxillofacial Surgery, School of Dentistry, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos 2492, 90035-003, Porto Alegre, RS, Brazil.
Ponzoni
D
D
Artuzi
F E
FE
Martins
G L
GL
Calcagnotto
T
T
D000799:Angioedema / Q000209:etiology / Q000628:therapy*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005145:Face; D005146:Facial Asymmetry / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008047:Lip Diseases / Q000209:etiology / Q000628:therapy; D008334:Mandible / Q000601:surgery; D056948:Orthognathic Surgical Procedures / Q000009:adverse effects; D010027:Osteotomy / Q000009:adverse effects / Q000379:methods; D010894:Piroxicam / Q000031:analogs & derivatives / Q000627:therapeutic use; D011183:Postoperative Complications; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D014662:Vasoconstrictor Agents; D010894:Piroxicam; D006854:Hydrocortisone; D004837:Epinephrine; C032801:tenoxicam